BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28898887)

  • 1. Angelman Syndrome due to a Maternally Inherited Intragenic Deletion Encompassing Exons 7 and 8 of the UBE3A Gene.
    Ververi A; Islam L; Bewes B; Busby L; Sullivan C; Canham N
    Cytogenet Genome Res; 2017; 152(3):132-136. PubMed ID: 28898887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
    Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
    Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.
    Aguilera C; Viñas-Jornet M; Baena N; Gabau E; Fernández C; Capdevila N; Cirkovic S; Sarajlija A; Miskovic M; Radivojevic D; Ruiz A; Guitart M
    BMC Med Genet; 2017 Nov; 18(1):137. PubMed ID: 29162042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical cases of Angelman syndrome.
    Lawson-Yuen A; Wu BL; Lip V; Sahoo T; Kimonis V
    Am J Med Genet A; 2006 Nov; 140(21):2361-4. PubMed ID: 17036311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling.
    Moncla A; Malzac P; Livet MO; Voelckel MA; Mancini J; Delaroziere JC; Philip N; Mattei JF
    J Med Genet; 1999 Jul; 36(7):554-60. PubMed ID: 10424818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angelman syndrome - insights into a rare neurogenetic disorder.
    Buiting K; Williams C; Horsthemke B
    Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological aspects of the Angelman syndrome.
    Williams CA
    Brain Dev; 2005 Mar; 27(2):88-94. PubMed ID: 15668046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phenotypes distinguish the molecular classes of Angelman syndrome.
    Lossie AC; Whitney MM; Amidon D; Dong HJ; Chen P; Theriaque D; Hutson A; Nicholls RD; Zori RT; Williams CA; Driscoll DJ
    J Med Genet; 2001 Dec; 38(12):834-45. PubMed ID: 11748306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-Phenotype Correlations in Angelman Syndrome.
    Yang L; Shu X; Mao S; Wang Y; Du X; Zou C
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34203304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.
    Matsuura T; Sutcliffe JS; Fang P; Galjaard RJ; Jiang YH; Benton CS; Rommens JM; Beaudet AL
    Nat Genet; 1997 Jan; 15(1):74-7. PubMed ID: 8988172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation of the ubiquitin protein ligase E3A gene in a patient with Angelman syndrome.
    Bai JL; Qu YJ; Zou LP; Yang XY; Liu LJ; Song F
    Chin Med J (Engl); 2011 Jan; 124(1):84-8. PubMed ID: 21362313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of UBE3A in brothers with Angelman syndrome at the breakpoint with an inversion at 15q11.2.
    Kuroda Y; Ohashi I; Saito T; Nagai J; Ida K; Naruto T; Wada T; Kurosawa K
    Am J Med Genet A; 2014 Nov; 164A(11):2873-8. PubMed ID: 25099823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angelman syndrome: a review of the clinical and genetic aspects.
    Clayton-Smith J; Laan L
    J Med Genet; 2003 Feb; 40(2):87-95. PubMed ID: 12566516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of UBE3A gene in patients referred for Angelman Syndrome.
    Tzagkaraki E; Sofocleous C; Fryssira-Kanioura H; Dinopoulos A; Goulielmos G; Mavrou A; Kitsiou-Tzeli S; Kanavakis E
    Eur J Paediatr Neurol; 2013 Jul; 17(4):366-73. PubMed ID: 23416059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel deletion encompassing exons 5-12 of the UBE3A gene in a girl with Angelman syndrome.
    Beleza-Meireles A; Cerqueira R; Sousa SB; Palmeiro A; Ramos L
    Eur J Med Genet; 2011; 54(3):348-50. PubMed ID: 21397058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial interstitial 570 kbp deletion of the UBE3A gene region causing Angelman syndrome but not Prader-Willi syndrome.
    Bürger J; Horn D; Tönnies H; Neitzel H; Reis A
    Am J Med Genet; 2002 Aug; 111(3):233-7. PubMed ID: 12210318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angelman syndrome due to a termination codon mutation of the UBE3A gene.
    Al-Maawali A; Machado J; Fang P; Dupuis L; Faghfoury H; Mendoza-Londono R
    J Child Neurol; 2013 Mar; 28(3):392-5. PubMed ID: 22566713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blended phenotype of combination of HERC2 and AP3B2 deficiency and Angelman syndrome caused by paternal isodisomy of chromosome 15.
    Ueda K; Ogawa S; Matsuda K; Hasegawa Y; Nishi E; Yanagi K; Kaname T; Yamamoto T; Okamoto N
    Am J Med Genet A; 2021 Oct; 185(10):3092-3098. PubMed ID: 34042275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations.
    Mertz LG; Thaulov P; Trillingsgaard A; Christensen R; Vogel I; Hertz JM; Ostergaard JR
    Res Dev Disabil; 2014 Jul; 35(7):1742-7. PubMed ID: 24656292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.